18 minutes agoU.S. decisions on the use of an anti-invention drug COVID-19
Periskopi(6 years ago)
(6 years ago)American regulators will allow the use of experimental medicine, remdesivivir, which seems to help some coronary patients heal more quickly. It's the first drug he's shown to help hit the virus. The U.S. Food and Bars Agency, The FDA granted authorisation Friday, as preliminary results [...]
It's the first drug he's shown to help hit the virus.
The U.S. Food and Bars Agency, The FDA granted authorisation Friday after the preliminary results of a government - requested expert study showed that it revived and accelerated the recovery of patients with COVID-19 percent.
President Donald Trump delivered the news Friday at the White House, along with agency head Stephen Hahn.
The medicine may even reduce the death toll, though it is not certain of the partial results that have emerged so far.
The pharmaceutical company Gilead Sciences has said it will donate current drug reserves and expand the production of other quantities.
The study of 1,033 patients is the largest and most rigorous drug patient and included a group of patients who received common care to compare the effect.
The remdesiviriers were able to leave the hospital after 11 days, compared with the average of 15 days in the next group.
U.S. lead expert on infectious diseases, Dr. Anthony Fauci said the drug would set a new standard of treatment for seriously ill people with COVID-19.
The medicine has not yet been tested on patients with milder symptoms and is currently given in serum at the hospital.
The FDA authorized the drug based on the competencies for emergency cases to accelerate medicines, tests and experimental products in cases of health crisis. /Vosa/
